vs

Side-by-side financial comparison of BIOHARVEST SCIENCES INC. (BHST) and FIRST CAPITAL INC (FCAP). Click either name above to swap in a different company.

FIRST CAPITAL INC is the larger business by last-quarter revenue ($13.5M vs $8.4M, roughly 1.6× BIOHARVEST SCIENCES INC.).

BioHarvest Sciences Inc. is a biotechnology firm that develops and produces sustainable, high-purity plant-derived bioactive ingredients. It serves the nutraceutical, cosmetics, and pharmaceutical sectors, leveraging proprietary cell cultivation technology to create efficacious natural products without large-scale agricultural farming.

Capital First Ltd, formerly known as Future Capital Holdings, was an Indian non-bank financial institution which provided debt financing. In December 2018, it was merged into IDFC Bank to form IDFC First Bank. The company was listed on the NSE and BSE prior to the merger.

BHST vs FCAP — Head-to-Head

Bigger by revenue
FCAP
FCAP
1.6× larger
FCAP
$13.5M
$8.4M
BHST

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BHST
BHST
FCAP
FCAP
Revenue
$8.4M
$13.5M
Net Profit
$4.9M
Gross Margin
60.3%
Operating Margin
Net Margin
36.2%
Revenue YoY
19.0%
Net Profit YoY
49.6%
EPS (diluted)
$1.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BHST
BHST
FCAP
FCAP
Q4 25
$13.5M
Q3 25
$8.4M
$13.3M
Q2 25
$8.1M
$12.4M
Q1 25
$7.7M
$11.4M
Q4 24
$11.3M
Q3 24
$6.5M
$10.9M
Q2 24
$6.0M
$10.7M
Q1 24
$10.5M
Net Profit
BHST
BHST
FCAP
FCAP
Q4 25
$4.9M
Q3 25
$4.5M
Q2 25
$3.8M
Q1 25
$3.2M
Q4 24
$3.3M
Q3 24
$2.9M
Q2 24
$2.8M
Q1 24
$3.0M
Gross Margin
BHST
BHST
FCAP
FCAP
Q4 25
Q3 25
60.3%
Q2 25
60.0%
Q1 25
58.2%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
BHST
BHST
FCAP
FCAP
Q4 25
Q3 25
41.8%
Q2 25
37.2%
Q1 25
34.2%
Q4 24
34.8%
Q3 24
31.5%
Q2 24
31.1%
Q1 24
33.0%
Net Margin
BHST
BHST
FCAP
FCAP
Q4 25
36.2%
Q3 25
33.8%
Q2 25
30.4%
Q1 25
28.3%
Q4 24
28.8%
Q3 24
26.5%
Q2 24
26.5%
Q1 24
28.1%
EPS (diluted)
BHST
BHST
FCAP
FCAP
Q4 25
$1.45
Q3 25
$1.34
Q2 25
$1.13
Q1 25
$0.97
Q4 24
$0.97
Q3 24
$0.87
Q2 24
$0.85
Q1 24
$0.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BHST
BHST
FCAP
FCAP
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
Stockholders' EquityBook value
$137.8M
Total Assets
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Stockholders' Equity
BHST
BHST
FCAP
FCAP
Q4 25
$137.8M
Q3 25
$132.4M
Q2 25
$123.2M
Q1 25
$120.1M
Q4 24
$114.6M
Q3 24
$116.8M
Q2 24
$107.8M
Q1 24
$105.7M
Total Assets
BHST
BHST
FCAP
FCAP
Q4 25
$1.3B
Q3 25
$1.2B
Q2 25
$1.2B
Q1 25
$1.2B
Q4 24
$1.2B
Q3 24
$1.2B
Q2 24
$1.2B
Q1 24
$1.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BHST
BHST
FCAP
FCAP
Operating Cash FlowLast quarter
$21.3M
Free Cash FlowOCF − Capex
$19.9M
FCF MarginFCF / Revenue
147.7%
Capex IntensityCapex / Revenue
10.0%
Cash ConversionOCF / Net Profit
4.36×
TTM Free Cash FlowTrailing 4 quarters
$35.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BHST
BHST
FCAP
FCAP
Q4 25
$21.3M
Q3 25
$7.9M
Q2 25
$3.7M
Q1 25
$4.4M
Q4 24
$22.3M
Q3 24
$7.6M
Q2 24
$3.5M
Q1 24
$7.2M
Free Cash Flow
BHST
BHST
FCAP
FCAP
Q4 25
$19.9M
Q3 25
$7.8M
Q2 25
$3.5M
Q1 25
$4.2M
Q4 24
$21.6M
Q3 24
$7.5M
Q2 24
$3.3M
Q1 24
$7.1M
FCF Margin
BHST
BHST
FCAP
FCAP
Q4 25
147.7%
Q3 25
58.6%
Q2 25
27.8%
Q1 25
36.5%
Q4 24
190.7%
Q3 24
68.6%
Q2 24
31.2%
Q1 24
67.2%
Capex Intensity
BHST
BHST
FCAP
FCAP
Q4 25
10.0%
Q3 25
1.2%
Q2 25
2.2%
Q1 25
1.9%
Q4 24
6.3%
Q3 24
0.8%
Q2 24
1.4%
Q1 24
1.5%
Cash Conversion
BHST
BHST
FCAP
FCAP
Q4 25
4.36×
Q3 25
1.77×
Q2 25
0.99×
Q1 25
1.36×
Q4 24
6.84×
Q3 24
2.62×
Q2 24
1.23×
Q1 24
2.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons